title: Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
authors.forename: F
authors.initials: F
authors.lastname: Schlemmer
authors.forename: M
authors.initials: M
authors.lastname: Lagrange-Xélot
authors.forename: C
authors.initials: C
authors.lastname: Lacroix
authors.forename: R
authors.initials: R
authors.lastname: de La Tour
authors.forename: G
authors.initials: G
authors.lastname: Socié
authors.forename: J-M
authors.initials: JM
authors.lastname: Molina
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage*; D006801:Humans; D008224:Lymphoma, Follicular / Q000382:microbiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000382:microbiology / Q000517:prevention & control*; D012220:Rhinitis / Q000382:microbiology / Q000517:prevention & control; D012233:Rhizopus; D012852:Sinusitis / Q000382:microbiology / Q000517:prevention & control; D033581:Stem Cell Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole